Wednesday, November 24, 2010

Marchman Act Blog: FDA Recommends Pulling Propoxyphene Products, Darvon and Darvocet

One of the makers of pain medications Darvon and Darvocet will stop marketing the drugs after new studies showed they can create abnormal heart rhythms even at normal doses, The Wall Street Journal reported Nov. 20.

Propoxyphene is the active ingredient in Darvon, which was first marketed in 1957. Darvocet contains propoxyphene and acetaminophen. Both were developed by Eli Lilly & Company, which no longer makes either drug. Currently, generic drugs companies, such as Xanodyne Pharmaceuticals and Qualitest/Vintage Pharmaceuticals, produce them instead.
Read Full Story...

No comments: